Skip to main content
Fig. 1 | Thrombosis Journal

Fig. 1

From: Clot time ratio (CTR) and relation to treatment outcome in patients with atrial fibrillation treated with Rivaroxaban

Fig. 1

Clot time ratio in trough and peak samples. Comparison of mean CTR at trough (A, C) and peak (B, D) measured in plasma samples from 30 patients on Rivaroxaban 20 (A-B) and 30 patients on Rivaroxaban 15 (C-D) using PT DOAC. The bottom and top of the box represent the first and third quartiles (Q1-Q3), while the band inside the box represents the median

Back to article page

Thrombosis Journal

ISSN: 1477-9560

Contact us